CompoAtlas

Nicorette Lozenge

Texto original en francés.

Producto de salud natural autorizado en Canadá

Otros nombres
Nicorette® Mini Lozenge
Titular
Kenvue Canada Inc.
NPN o DIN-HM
02247347
Estado
Licencia activa
Fecha de licencia
13 de diciembre de 2007
Fecha de revisión
26 de julio de 2024
Forma
Pastille
Vía de administración
Buccale
Tipo de solicitud
DIN de transition

El análisis de dosis orales no se aplica sin una vía exclusivamente oral establecida.

Composición

Ingrediente medicinal y fuentePor unidad posológica, según la fuente
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine

Fuente : Nicotine polacrilex

2 mg

Ingredientes no medicinales

Gomme de xanthane, Acesulfame Potassium, Menthe poivrée, Stéarate de magnésium, Carbonate de sodium anhydre, Saveur de menthol, Eau, Masking flavour, mannitol, calcium polycarbophil, Sodium alginate, Bicarbonate de potassium

Dosis recomendadas en Canadá

PoblaciónEdadCantidad por tomaFrecuencia
Adultesminimum : 18 ans1 Pastillemaximum : 15 Tous les jours

Usos autorizados en Canadá

NICORETTE(R) Lozenge is a medicine that can help you stop smoking by reducing withdrawal symptoms and nicotine cravings. NICORETTE(R) Lozenge is a form of Nicotine Replacement Therapy (NRT) that can help double your chances of quitting successfully. NICORETTE(R) Lozenge provides a lower level of nicotine to your blood than cigarettes and allows you to slowly decrease your body's need for nicotine. It works as a temporary aid to help you quit smoking by reducing nicotine withdrawal symptoms such as irritability, frustration, anxiety, difficulty in concentration and restlessness. Without these powerful urges for the cigarettes you "need", getting rid of the "habit" cigarettes becomes much easier. The good news is that NICORETTE(R) Lozenge contains no tar or carbon monoxide, and therefore doesn't present the same medical risks as cigarettes. NICORETTE(R) Lozenge can be used to quit immediately or to quit gradually by reducing the number of cigarettes you smoke each day before making a quit attempt. Although smoking cessation is preferable, it can also be used in cases in which you temporarily refrain from smoking, for example, in smoke-free areas or in other situations when you wish to avoid smoking. Combination Nicotine Replacement Therapy - patch + as needed lozenge versus the nicotine patch or lozenge alone is: o Clinically proven to increase your chances of quitting. o A clinically proven approach to increase your chances of quitting. oIf you have relapse or experience tough/intense cravings or failed with lozenge alone, you can use NICORETTE® lozenge with the patch at the same time to increase your chances of quit success. o Now you can have the combined support of NICODERM® patch and NICORETTE® as needed lozenge products together, for a successful quit. o Tackle cravings: NICODERM® (patch) for slow release constant support and NICORETTE as needed lozenge for an extra quick fix/dose when you really need to fight back the cravings / when something triggers intense cravings. o Combination therapy is 18%/1.18x more effective than using one Nicotine Replacement Therapy product alone. o Use NICODERM® patch + NICORETTE® lozenge together to increase your chance of quitting.

Texto original en inglés.

Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.

Advertencias en Canadá

Cautions and Warnings : Consult your doctor before using this product if you have/have had heart, thyroid, circulation, stomach problems, high blood pressure, or if you are taking insulin or any prescription medicine. If you have diabetes, you may need to monitor your blood sugar levels more closely than normal when you stop smoking and start using this product. Keep out of reach of children and pets.

Texto original en inglés.

Cautions and Warnings : Before you use NICORETTE® Lozenge talk to your doctor or pharmacist if you have/have had: -stomach ulcer or esophagitis, throat, mouth or dental problems -angina, coronary artery disease, high blood pressure, irregular heartbeat, peripheral vascular disease -kidney or liver problems, a tumour of the adrenal gland (phaeochromocytoma), treatment for circulation disorders of the brain

Texto original en inglés.

Cautions and Warnings : Stop using NICORETTE® Lozenge and consult your doctor if: -mouth problems occur -chest pain or leg pain occurs, irregular heartbeat or palpitations occur, or if severe persistent stomach upset (indigestion, heartburn) develops -symptoms persist or get worse, or if new symptoms occur

Texto original en inglés.

Fuente

Ficha oficial de Health Canada, licencia 02247347

Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Texto original en inglés.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Texto original en francés.

La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.

Lista en la revisión oficial del (registro: Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias).

Fotografiar el envase

¿Alguna información inexacta o más reciente sobre este producto, sea usted lector o marca? Escriba a contact@compoatlas.com: cada corrección se publica en el registro de correcciones.

Lista registrada en 2024. Fotografíe el envase para comprobar si ha cambiado.

Intro para analizar, Mayús+Intro para una nueva línea